McSherry E
Kidney Int. 1978 Oct;14(4):349-54. doi: 10.1038/ki.1978.135.
Our data demonstrate that correction of acidosis is sustained in children with type 1 RTA when alkali therapy is given in doses of 5 to 14 mEq/kg/day. The large doses are required as a result of renal bicarbonate-wasting. Children with type 1 RTA and acidosis who have significant growth impairment experience catch-up growth and attain normal stature for their age when correction of acidosis is sustained. Whether chronic acidosis impairs growth in any clinical condition except type 1 RTA is not settled. Whether sustained correction of acidosis with alkali therapy will allow attainment of normal stature in children with nonuremic diffuse renal disease is not yet determined. With the increasing availability of microchemistry and microgasometry and the new standards for growth based on mean-parent height [40], it can be anticipated that answers to these clinically important questions will be forthcoming.
我们的数据表明,对于1型肾小管酸中毒(RTA)患儿,当给予5至14 mEq/kg/天剂量的碱疗法时,酸中毒的纠正能够持续。由于肾脏碳酸氢盐的流失,需要大剂量的碱。1型RTA和酸中毒且有显著生长发育障碍的患儿,当酸中毒持续得到纠正时,会出现追赶生长并达到其年龄对应的正常身高。除1型RTA外,慢性酸中毒是否会在任何临床情况下损害生长发育尚无定论。碱疗法持续纠正酸中毒是否能使非尿毒症性弥漫性肾病患儿达到正常身高尚未确定。随着微量化学和微量气体测定技术的日益普及以及基于父母平均身高的新生长标准的出现[40],可以预期这些临床上重要问题的答案即将出现。